Return to Search
EN
Heart valves are crucial for maintaining the heart's pumping efficiency, ensuring one-way blood flow. They must open fully to allow forward flow and close completely to prevent backflow. When valves malfunction, either by failing to open adequately (stenosis) or by allowing blood to leak backward (insufficiency or regurgitation), they impose an excessive workload on the heart.
Surgical intervention becomes necessary to address these issues. The primary goal is to restore normal valve function, ideally through repair rather than replacement, as repair preserves the heart's natural structures. Commonly repaired valves include the mitral valve and the tricuspid valve, located between the atria and ventricles.
While not all valve conditions are amenable to repair, excellent outcomes are often achieved in cases such as valve ring dilation, prolapse (sagging), or elongation, which lead to valve insufficiency. However, severe calcification and thickening, often seen in rheumatic heart disease, can limit repair options. Mitral insufficiency can also arise from acute events like myocardial infarction or endocarditis, where structures supporting the valve (chordae tendineae) are damaged. In such instances, valve repair may be performed concurrently with coronary bypass surgery.
A significant advantage of valve repair is its long-term durability, often exceeding 10 years. During the surgery, real-time "Transesophageal Echocardiography" (TEE) provides detailed assessment of valve structure and function. The success of the procedure relies heavily on the expertise of both the surgical team and the anesthesiologist/cardiologist performing the TEE, allowing for immediate confirmation of repair success.
When repair is not feasible, valve replacement with a prosthetic valve is performed. Prosthetic valves come in two main types, each with specific considerations:
1. Mechanical Valves (Metal): These are highly durable but necessitate lifelong anticoagulation therapy to prevent blood clot formation on the valve, which could lead to serious complications like stroke.
2. Bioprosthetic Valves (Tissue): Derived from animal tissue, these valves require only short-term anticoagulation (typically 3-6 months). However, their main limitation is a finite lifespan, as they are prone to calcification and degeneration, often requiring re-replacement within approximately 10-15 years.
Furthermore, replacing certain valves, especially the mitral or tricuspid valve, can involve detaching or cutting the subvalvular apparatus (muscles and chords) that connect the valve to the heart muscle. These structures play a vital role in both valve function and overall cardiac contraction. Preserving them through repair helps maintain superior cardiac performance compared to replacement. Therefore, if repair is technically possible and expected to provide long-term physiological stability, it is generally preferred over replacement.
Post-operative recovery after valve repair involves a healing period of 3 to 6 months during which the surgical sites and any supporting prosthetic rings are covered by the body's own tissue. During this crucial period, anticoagulant medication is administered to prevent clot formation. Regular blood tests, such as INR monitoring (which can now be done with home devices), are required to adjust medication dosage. After this initial healing phase, annual follow-up with a cardiologist, including echocardiography, is typically sufficient.
How is heart valve replacement or repair performed?
Surgical intervention becomes necessary to address these issues. The primary goal is to restore normal valve function, ideally through repair rather than replacement, as repair preserves the heart's natural structures. Commonly repaired valves include the mitral valve and the tricuspid valve, located between the atria and ventricles.
While not all valve conditions are amenable to repair, excellent outcomes are often achieved in cases such as valve ring dilation, prolapse (sagging), or elongation, which lead to valve insufficiency. However, severe calcification and thickening, often seen in rheumatic heart disease, can limit repair options. Mitral insufficiency can also arise from acute events like myocardial infarction or endocarditis, where structures supporting the valve (chordae tendineae) are damaged. In such instances, valve repair may be performed concurrently with coronary bypass surgery.
A significant advantage of valve repair is its long-term durability, often exceeding 10 years. During the surgery, real-time "Transesophageal Echocardiography" (TEE) provides detailed assessment of valve structure and function. The success of the procedure relies heavily on the expertise of both the surgical team and the anesthesiologist/cardiologist performing the TEE, allowing for immediate confirmation of repair success.
When repair is not feasible, valve replacement with a prosthetic valve is performed. Prosthetic valves come in two main types, each with specific considerations:
1. Mechanical Valves (Metal): These are highly durable but necessitate lifelong anticoagulation therapy to prevent blood clot formation on the valve, which could lead to serious complications like stroke.
2. Bioprosthetic Valves (Tissue): Derived from animal tissue, these valves require only short-term anticoagulation (typically 3-6 months). However, their main limitation is a finite lifespan, as they are prone to calcification and degeneration, often requiring re-replacement within approximately 10-15 years.
Furthermore, replacing certain valves, especially the mitral or tricuspid valve, can involve detaching or cutting the subvalvular apparatus (muscles and chords) that connect the valve to the heart muscle. These structures play a vital role in both valve function and overall cardiac contraction. Preserving them through repair helps maintain superior cardiac performance compared to replacement. Therefore, if repair is technically possible and expected to provide long-term physiological stability, it is generally preferred over replacement.
Post-operative recovery after valve repair involves a healing period of 3 to 6 months during which the surgical sites and any supporting prosthetic rings are covered by the body's own tissue. During this crucial period, anticoagulant medication is administered to prevent clot formation. Regular blood tests, such as INR monitoring (which can now be done with home devices), are required to adjust medication dosage. After this initial healing phase, annual follow-up with a cardiologist, including echocardiography, is typically sufficient.